Germany's telecoms regulator says Huawei can stay in the 5G network race, the European Central Bank faces stimulus pressure over a falling inflation outlook and the FT reports that Purdue Pharma, the makers of Oxycontin, tried to buy Reckitt Benckiser's addiction treatment business. Plus, the FT's Camilla Hodgson sets up the $30bn legal battle between Apple and Qualcomm that will play out in a San Diego court on Monday.

A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on FT News Briefing when a new story is published

Copyright The Financial Times Limited 2019. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this podcast.

Follow the topics in this podcast